UBE Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 5 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/02/04 | ¥76.30 | ¥112.58 | +47.6% |
| 2021/02/01 | ¥64.30 | ¥86.04 | +33.8% |
| 2020/10/30 | ¥63.60 | ¥15.85 | -75.1% |
| 2020/05/13 | ¥57.15 | ¥77.17 | +35.0% |
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥55 | -50.0% |
| 2025 | ¥110 | 0.0% |
| 2024 | ¥110 | +15.8% |
| 2023 | ¥95 | -5.0% |
| 2022 | ¥100 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥655,265M | ¥494,738M | ¥468,237M | ¥486,802M |
| Gross Profit | ¥127,919M | ¥82,545M | ¥86,711M | ¥90,933M |
| Operating Income | ¥44,038M | ¥16,210M | ¥22,456M | ¥18,045M |
| Pretax Income | ¥37,692M | -¥1,872M | ¥36,110M | -¥9,160M |
| Net Income | ¥24,500M | -¥7,034M | ¥28,981M | -¥4,816M |
| EPS | ¥248.56 | -¥72.54 | ¥298.45 | -¥49.60 |
| Operating Margin | 6.72% | 3.28% | 4.80% | 3.71% |
| Balance Sheet | ||||
| Total Assets | ¥837,954M | ¥732,681M | ¥789,034M | ¥865,669M |
| Total Equity | ¥369,652M | ¥361,682M | ¥408,751M | ¥395,102M |
| Total Liabilities | ¥468,302M | ¥370,999M | ¥380,283M | ¥470,567M |
| Cash | ¥79,492M | ¥31,175M | ¥36,359M | ¥115,969M |
| Interest-bearing Debt | ¥241,812M | ¥218,143M | ¥213,432M | ¥330,536M |
| Equity Ratio | 44.11% | 49.36% | 51.80% | 45.64% |
| D/E Ratio | 0.65 | 0.60 | 0.52 | 0.84 |
| Cash Flow | ||||
| Operating CF | ¥32,711M | ¥18,127M | ¥52,960M | ¥35,837M |
| Investing CF | -¥43,373M | -¥26,019M | -¥33,316M | -¥63,152M |
| Financing CF | ¥8,371M | ¥2,443M | -¥15,712M | ¥105,851M |
| Free CF | -¥3,668M | -¥8,702M | ¥21,988M | -¥23,093M |
| Efficiency | ||||
| ROE | 6.63% | -1.94% | 7.09% | -1.22% |
| ROA | 2.92% | -0.96% | 3.67% | -0.56% |
Latest IR Information
-
【Uber】Completion of Share Buyback Disposal｜July 24, 2026
Uber Technologies Inc. announced the completion of its share buyback disposal on July 24, 2026. Details regarding the type and number of shares disposed of, as well as the disposal amount, are disclosed.
Read more -
UBE-Mitsubishi Cement Announces Application for Listing on the Tokyo Stock Exchange
UBE-Mitsubishi Cement announces its application for listing on the Tokyo Stock Exchange. Aiming to realize the growth vision for 2030, the medium-term management strategy from fiscal 2026 onward will focus on strengthening domestic earnings power, international growth, and sustainability management....
Read more -
Notice Regarding Receipt of Dividends from Equity-Method Investee
Received dividend of 37,016 million yen from UBE Mitsubishi Cement, an equity-method investee. The dividend payment is expected to be made on June 30, 2026. No impact is anticipated on performance for the fiscal year ending March 2027.
Read more -
Notice of Share Buyback under Restricted Stock Compensation Scheme
UBＥ Corporation plans to dispose of 29,100 shares of treasury stock on July 24, 2026, and allocate them to directors and officers under the restricted stock compensation scheme. The disposal price is 3,108 yen per share, totaling 90,440,000 yen.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥3,500
Rating Score: 2.33 (Based on 5 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin intermediate, elastomers, and coating products. Its Pharmaceuticals segments engages in the drug discovery and the contract manufacturing and sales of pharmaceutical raw materials and intermediates. The Resin and Chemical Products segment provides composite, nylon polymer, caprolactam, ammonium sulfate, industrial chemicals, and elastomer. Its Machinery segment offers die casting machines, extrusion presses, injection molding machines, ceramics machinery, chemical equipment, crushers, transport machines, dust removers, as well as bridges, steel structures, etc. The Other segment is involved in electricity supply, real estate sales, leasing, and management, etc. The company was formerly known as Ube Industries, Ltd. UBE Corporation was founded in 1897 and is headquartered in Minato, Japan.
